Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the Company on 16 August 2024.Powered by Capital Market - Live News

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the Company on 8 March 2024.Powered by Capital Market - Live News

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) of the company will be held on 29 December 2023.Powered by Capital Market - Live News

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) of the company will be held on 29 December 2023.Powered by Capital Market - Live News

Net Loss of Bharat Immunological & Biological Corporation reported to Rs 4.92 crore in the quarter ended September 2023 as against net loss of Rs 3.08 crore during the previous quarter ended September 2022. There were no Sales reported in the quarter ended September 2023 as against Rs 26.48 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales026.48 -100 OPM %0-9.44 - PBDT-6.62-3.92 -69 PBT-6.65-3.96 -68 NP-4.92-3.08 -60 Powered by Capital Market - Live News